KPP Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
KPP Advisory Services's VRTX Position: Q1 2026 in Review
KPP Advisory Services reduced its Vertex Pharmaceuticals (VRTX) stake by 3.6% in Q1 2026, selling an estimated $10.3K and leaving 591 shares worth $264K. The position accounts for 0.04% of the portfolio, ranked #298.
KPP Advisory Services first reported a position in VRTX in Q1 2025 and has held it in 4 quarters since. The position peaked at $440K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- KPP Advisory Services held 591 shares of Vertex Pharmaceuticals worth $264K as of Q1 2026.
- KPP Advisory Services sold 22 Vertex Pharmaceuticals shares in Q1 2026, an estimated $10.3K.
- Vertex Pharmaceuticals made up 0.04% of KPP Advisory Services's portfolio in Q1 2026, its #298 holding.
- KPP Advisory Services first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
- KPP Advisory Services's Vertex Pharmaceuticals position peaked at $440K in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on KPP Advisory Services's 13F filing for Q1 2026, filed 24 Apr 2026.